HALO - HALOZYME THERAPEUTICS, INC.
70.02
0.620 0.885%
Share volume: 1,660,590
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$69.40
0.62
0.01%
Summary score
48%
Profitability
51%
Dept financing
24%
Liquidity
72%
Performance
45%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.31%
Return on assets
-0.83%
Return on sales
-22.76%
Return on invested capital
177.72%
Total debt ratio
67.96%
Debt ratio change over timeo
0%
Current Ratio
6.09%
Quick Ratio
5.63%
Cash Position Ratio
1.33%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.26%
Return on assets
3.11%
Return on sales
25.11%
Return on invested capital
671.18%
Total debt ratio
83.27%
Debt ratio change over timeo
0%
Current Ratio
13.79%
Quick Ratio
12.46%
Cash Position Ratio
2.87%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
36.58%
Return on assets
7.69%
Return on sales
61.7%
Return on invested capital
-1965.64%
Total debt ratio
81.11%
Debt ratio change over time
0%
Current Ratio
18.49%
Quick Ratio
16.36%
Cash Position Ratio
2.44%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HALO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 7.31% | 12.3% | 4.66% | 8.41% |
| Return on assets | -0.83% | 3.6% | 3.82% | 5.9% |
| Return on sales | -22.76% | 41.82% | 38.61% | 44.98% |
| Return on invested capital | 177.72% | 7.81% | 4.85% | 8.03% |
| Profitability | 40% | 65% | 48% | 68% |
| Total debt ratio | 67.96% | 75.51% | 65.79% | 48.93% |
| Debt ratio change over time | 0% | 0% | 341.77% | 4.46% |
| Dept financing | 23% | 25% | 47% | 17% |
| Current Ratio | 13.79% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 12.46% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 2.87% | 0.73% | 2.29% | 0.99% |
| Liquididy | 65% | 36% | 51% | 29% |
| Short-term ratios | HALO | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 3.26% | 18.05% | 0.63% | 10.52% |
| Return on assets | 3.11% | 3.58% | 3.44% | 6.39% |
| Return on sales | 25.11% | 36.22% | 35.02% | 46.53% |
| Return on invested capital | 671.18% | 5.97% | 1.16% | 9.33% |
| Profitability | 55% | 59% | 33% | 65% |
| Total debt ratio | 83.27% | 83.77% | 66.41% | 53.87% |
| Debt ratio change over time | 0% | 0% | -1.12% | 4.06% |
| Dept financing | 25% | 25% | 20% | 41% |
| Current Ratio | 13.79% | 1.87% | 2.93% | 1.99% |
| Quick Ratio | 12.46% | 1.53% | 2.83% | 1.77% |
| Cash Position Ratio | 2.87% | 0.73% | 2.29% | 0.99% |
| Liquididy | 75% | 13% | 31% | 16% |